Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 40 for:    "Yellow fever"

The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00708630
Recruitment Status : Completed
First Posted : July 2, 2008
Last Update Posted : July 30, 2012
Sponsor:
Information provided by (Responsible Party):
Keith J Petrie, University of Auckland, New Zealand

Brief Summary:
This study aims to investigate the effect of providing additional information about possible mild side effects of the yellow fever vaccination on the reporting of physical symptoms. Additionally, the project aims to investigate the relationship between individual characteristics (trait anxiety and perceived sensitivity to medication) and the reporting of physical symptoms, as well as possible interactions between the level of information provided and individual characteristics. We hypothesize that more information about mild symptoms provided to participants will increase the number of reported symptoms after vaccination.

Condition or disease Intervention/treatment Phase
Vaccination Behavioral: Extended information on side effects Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination
Study Start Date : June 2008
Actual Primary Completion Date : September 2008
Actual Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fever

Arm Intervention/treatment
Experimental: 1
Provision of extended symptom side effects information
Behavioral: Extended information on side effects
More detailed information on possible side effects of vaccine

No Intervention: 2
Standard information on side effects



Primary Outcome Measures :
  1. symptom report scale [ Time Frame: 20 minutes and 1 week post vaccination ]

Secondary Outcome Measures :
  1. patient satisfaction scale [ Time Frame: 20 minutes and 1 week post vaccination ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Receiving yellow fever vaccination
  • English speaker
  • Aged over 18

Exclusion Criteria:

  • No phone for follow-up

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00708630


Locations
Layout table for location information
New Zealand
Worldwise Travellers Health
Auckland, New Zealand, 10021
Sponsors and Collaborators
University of Auckland, New Zealand
Investigators
Layout table for investigator information
Principal Investigator: Keith J Petrie, PhD University of Auckland, New Zealand
Principal Investigator: Kate E Faasse, BSc University of Auckland, New Zealand

Layout table for additonal information
Responsible Party: Keith J Petrie, Professor, University of Auckland, New Zealand
ClinicalTrials.gov Identifier: NCT00708630     History of Changes
Other Study ID Numbers: KPKF001
First Posted: July 2, 2008    Key Record Dates
Last Update Posted: July 30, 2012
Last Verified: July 2012

Keywords provided by Keith J Petrie, University of Auckland, New Zealand:
yellow fever vaccine
patient information
symptom reports
patient satisfaction

Additional relevant MeSH terms:
Layout table for MeSH terms
Yellow Fever
Arbovirus Infections
Virus Diseases
Flavivirus Infections
Flaviviridae Infections
RNA Virus Infections
Hemorrhagic Fevers, Viral
Vaccines
Immunologic Factors
Physiological Effects of Drugs